20996 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Calcitonins
ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS
#2COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION
#3MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#4ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS
#5LIPID DEPOT FORMULATIONS
#6Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) Inhibitors
#7DOSING OF INCRETIN PATHWAY DRUGS
#8ROOM TEMPERATURE STABLE ORAL CALCITONIN FORMULATION
#9A COMPOSITION COMPRISING NANOSIZED ACTIVE PHARMACEUTICAL INGREDIENT
#10RAPIDLY DISSOLVING SALT TABLET COMPOSITIONS AND METHODS
#11COMPOSITIONS AND METHODS FOR ACTIVATING A NEURAL RECEPTOR
#12Treatment of Moderate-to-Severe Osteogenesis Imperfecta
#13Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#14METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#15METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
#16TREATMENT OF OSTEOGENESIS IMPERFECTA
#17INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#18Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#19STABLE PEPTIDE FORMULATIONS FOR ORAL USE
#20LIPID DEPOT FORMULATIONS
#21Room temperature stable oral calcitonin formulation
#22STABILISATION AND CONTROLLED-RELEASE SYSTEMS FOR MEDICAMENTS UNSTABLE ON STERILISATION
#23COMPOSITIONS AND METHODS FOR MODULATING CGRP SIGNALING TO REGULATE INTESTINAL INNATE LYMPHOID CELLS
#24LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREAST CANCER AND OTHER MALIGNANCIES
#25MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#26HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS
#27LIPID DEPOT FORMULATIONS
#28Degradable polyethylene glycol conjugate
#29Orally bioavailable lipid-based constructs
#30Methods of treating inflammatory skin disorders
#31Methods of treating inflammatory skin disorders
#32Methods of treating inflammatory skin disorders
#33Method for preparing micro-particles by double emulsion technique
#34Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration
#35BRAIN OSTEOCALCIN RECEPTOR AND COGNITIVE DISORDERS
#36ORAL DOSAGE FORM WITH DRYING AGENT FOR DELIVERY OF ACTIVE AGENT
#37METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#38Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
#39Heat-stable dry powder pharmaceutical compositions and methods
#40Calcitonin Analogues for Treating Diseases and Disorders
#41LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREAST CANCER AND OTHER MALIGNANCIES
#42NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#43Room temperature stable oral calcitonin formulation
#44Calcitonin Mimetics for Treating Diseases and Disorders
#45LIPID DEPOT FORMULATIONS
#46Calcitonin analogues for treating diseases and disorders
#47Heat-stable dry powder pharmaceutical compositions and methods
#48Peptide analogs for treating diseases and disorders
#49MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS
#50GNRH ANALOGUE FORMULATIONS
#51Polymeric Nanoparticle
#52Microneedle device having a peptide therapeutic agent and an amino acid and methods of making and using the same
#53Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use
#54MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS
#55Calcitonin mimetics for treating diseases and disorders
#56Compounds and methods for inducing chondrogenesis
#57Peptide analogs for treating diseases and disorders
#58Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents
#59CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES
#60Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
#61Aldehyde-tagged protein-based drug carriers and methods of use
#62Heat-stable dry powder pharmaceutical compositions and methods
#63Methods and compositions for delivering active agents with enhanced pharmacological properties
#64Polymers for delivery of therapeutic proteins
#65CGRP RECEPTOR AGONIST FOR HIV TREATMENT OR PREVENTION
#66Method for diagnosis of dementias and neuroinflammatory diseases based on an increased level of procalcitonin in cerebrospinal fluid
#67Oral Drug Devices and Drug Formulations
#68NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#69ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF
#70Pharmaceutical composition
#71Oral Drug Devices and Drug Formulations
#72Peptide analogs for treating diseases and disorders
#73Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
#74MUCOADHESIVE DEVICES FOR DELIVERY OF ACTIVE AGENTS
#75Controlled-Released Peptide Formulations
#76Methods and compositions for oral administration of protein and peptide therapeutic agents
#77Topical bioadhesive formulations
#78Orally bioavailable lipid-based constructs
#79Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders
#80TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#81Stabilised protein compositions based on semifluorinated alkanes
#82Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
#83Peptide pharmaceutical for oral delivery
#84Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
#85SUSTAINED-RELEASE MICROSPHERES AND METHODS OF MAKING AND USING SAME
#86Microspheres for controlled- or sustained-release delivery of therapeutics
#87USE OF CALCITONIN IN OSTEOARTHRITIS
#88Calcitonin products and therapies for treating inflammatory or degenerative diseases
#89Methods for the in situ treatment of bone cancer
#90LIPID DEPOT FORMULATIONS
#91Mucosal delivery of drugs
#92Compounds and methods for inducing chondrogenesis
#93A polymeric nanoparticle
#94Methods of delivering stable topical drug compositions
#95Methods of delivering stable topical drug compositions
#96TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#97Compositions for nasal administration of pharmaceuticals
#98Method for treating metabolic disorders including type 1 and type 2 diabetes mellitus
#99Peptide analogs for treating diseases and disorders
#100MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FORMULATIONS
#101Orally bioavailable lipid-based constructs
#102Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
#103Seizure and Migraine Treatments using Denosumab
#104Peptide pharmaceutical for oral delivery
#105EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS
#106Peptide pharmaceutical for oral delivery
#107Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
#108Lipid depot formulations
#109Use of Calcitonin for the Treatment of RA
#110STABILIZED PROTEIN FORMULATIONS AND USE THEREOF
#111Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet
#112Transdermal delivery system for therapeutics
#113Oral Delivery of Peptides
#114Dissolution aids for oral peptide delivery comprising a biguanide
#115ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION
#116Methods useful in the treatment of bone resorption diseases
#117Nasal calcitonin formulations containing chlorobutanol
#118Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
#119THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME
#120Modified amino acid for the inhibition of platelet aggregation
#121MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONS
#122Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#123Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#124COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES
#125CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES
#126AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS
#127TREATMENT OF DIABETES AND METABOLIC SYNDROME
#128ORAL DRUG DEVICES AND DRUG FORMULATIONS
#129Peptide pharmaceutical for oral delivery
#130Controlled-released peptide formulations
#131PHARMACEUTICAL COMPOSITION
#132COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES
#133USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
#134Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy
#135Methods for the In Situ Treatment of Bone Cancer
#136COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY
#137Topical drug delivery using phosphatidylcholine
#138Method Of Delivering Stable Topical Drug Compositions
#139ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF
#140Methods useful in the treatment of bone resorption diseases
#141Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder
#142Exendin and exendin agonists for eating disorders
#143Nasal calcitonin formulations containing chlorobutanol
#144Methods and compositions for oral administration of protein and peptide therapeutic agents
#145Treatment of Menorrhagia with Aromatase Inhibitor
#146TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#147METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN
#148Use of calcitonin in osteoarthritis
#149USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#150Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#151Aldehyde-tagged protein-based drug carriers and methods of use
#152Oral administration of a calcitonin
#153USE OF CALCITONIN AS ANTI-ANGIOGENIC AGENT
#154Bone microenvironment modulated seizure treatments
#155USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#156USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#157COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES
#158METHOD OF TREATING AND PREVENTING HYPERPARATHYROIDISM WITH ACTIVE VITAMIN D ANALOGS
#159Orally Bioavailable Lipid-Based Constructs
#160METHOD FOR SUSTAINEDLY RELEASING BIOACTIVE PEPTIDES AND APPLICATION THEREOF
#161HARMINE COMPOUNDS FOR PROMOTING BONE GROWTH
#162USE OF ANTIRESORPTIVE COMPOUNDS TO PREVENT IONIZING RADIATION-INDUCED ACTIVATION OF OSTEOCLASTS AND RESULTING BONE LOSS
#163Absorption enhancers such as E.G. BHT, BHA or propyl gallate
#164TRIMEPRAZINE AND ETHOPROPAZINE DERIVATIVES FOR PROMOTING BONE GROWTH
#165Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
#166Compounds and compositions for delivering active agents
#167Peptide pharmaceutical for oral delivery
#168Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
#169SOLID PHARMACEUTICAL COMPOSITION WITH A FIRST FRACTION OF A DISPERSION MEDIUM AND A SECOND FRACTION OF A MATRIX, THE LATTER BEING AT LEAST PARTIALLY FIRST EXPOSED TO GASTROINTESTINAL FLUIDS
#170Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
#171COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN
#172Compositions comprising SIA for the treatment of diabetes
#173Compounds and methods for increasing neurogenesis
#174Osteogenic and anti-adipogenic oxysterols
#175TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS
#176Orally Absorbed Pharmaceutical Formulation and Method of Administration
#177Exendin agonist analogs to treat diabetes
#178GnRH analogue formulations
#179Compositons for nasal administration of pharmaceuticals
#180BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING SUMATRIPTAN
#181Topical bioadhesive formulations
#182Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents
#183Methods useful in the treatment of bone resorption diseases
#184Bone microenvironment modulated migraine treatments
#185Orally bioavailable lipid-based constructs
#186Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
#187METHODS OF TREATING AND PREVENTING PRESSURE ULCERS WITH INTRADERMAL AND TRANSDERMAL DELIVERY OF CALCITONIN GENE-RELATED PEPTIDE (CGRP)
#188DISSOLUTION AIDS FOR ORAL PEPTIDE DELIVERY COMPRISING A BIGUANIDE
#189Nanoparticles for protein drug delivery
#190MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION
#191Activating extraction of demineralized bone matrix
#192Pharmaceutical Composition
#193Chitosan Containing Solution
#194Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
#195Use of calcitonin for the treatment of RA
#196Csf Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases
#197Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#198Use of Calcitonin as Combined Treatment Therapy for the Management of Inflammatory Disease Conditions
#199COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN
#200Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#201Sustained-release microspheres and methods of making and using same
#202Orally administering parathyroid hormone and calcitonin
#203Analogs of parathyroid hormone
#204Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
#205Method for prophylaxis of reflex sympathetic dystrophy after stroke
#206Liquid depot formulations
#207Analogs of parathyroid hormone
#208Compositions capable of facilitating penetration across a biological barrier
#209Opioid depot formulations
#210Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
#211Nanoparticles for protein/peptide delivery and delivery means
#212Oral administration of calcitonin
#213Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
#214Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass
#215Compositions capable of facilitation penetration across a biological barrier
#216Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#217TIGHT JUNCTION MODULATING PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS
#218Fast-acting oral peptide pharmaceutical products
#219COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#220Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#221BIOMARKERS FOR THE EFFICACY OF CALCITONIN AND PARATHYROID HORMONE TREATMENT
#222Compounds and compositions for delivering active agents
#223Compositions of lipids and cationic peptides
#224Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
#225Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#226Sustained release microparticles for pulmonary delivery
#227Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
#228Method of treatment and/or prevention of neuropathic pain
#229Methods for the in situ treatment of bone cancer
#230Stable topical drug delivery compositions
#231Agents and methods for enhancing bone formation
#232Compositions for nasal administration of pharmaceuticals
#233Absorption enhancers such as e.g. BHT, BHA or propyl gallate
#234Methods useful in the treatment of bone resorption diseases
#235Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#236Use of calcitonin in osteoarthritis
#237Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#238Pharmaceutical formulations for sustained drug delivery
#239Compounds and compositions for delivering active agents
#240Buccal, polar and non-polar spray containing sumatriptan
#241Use of exendins and agonists thereof to treat diabetes
#242Oral administration of calcitonin
#243Oral drug delivery compositions and methods
#244Methods of delivering stable topical drug compositions
#245Uptake of macromolecules
#246Modified amino acid for the inhibition of platelet aggregation
#247Topical drug delivery using phosphatidylcholine
#248Methods of treating and preventing bone loss
#249Compounds and methods for increasing neurogenesis
#250Use of neuropeptides for ligament healing
#251Compounds and compositions for delivering active agents
#252Lactone bearing absorbable polymers
#253Method and formula for anti-tumor and anti-matastatic effect
#254Active agent transport systems
#255Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
#256Pharmaceutical compositions containing exendins
#257Compounds and methods for increasing neurogenesis
#258Powders comprising low molecular dextran and methods of producing those powders
#259Compounds and compositions for delivering active agents
#260Sustained release drug formulations containing a carrier peptide
#261Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#262Treatment of subnormal bone mineral density
#263Composition and apparatus for transdermal delivery
#264Compounds and compositions for delivering active agents
#265Use of exendins and agonists thereof for lowering plasma lipid
#266Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
#267Methods of preventing or treating disorders by administering and integrin alphanubeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
#268Stabilized reverse micelle compositions and uses thereof
#269Exendins, exendin agonists, and methods for their use
#270Compositions capable of facilitating penetration across a biological barrier
#271Compositions for delivering parathyroid hormone and calcitonin
#272Exendins and exendin agonists for weight reduction and obesity
#273Method for promoting bone growth
#274Method of preparing biological materials and preparations produced using same
#275Compounds and methods for increasing neurogenesis
#276Hypotensive and hypertensive properties of renomedullar extracts